Pyrazinone derivatives and their use in the treatment of lung diseases

Details for Australian Patent Application No. 2008269516 (hide)

Owner AstraZeneca AB

Inventors Brough, Stephen; Luker, Timothy Jon; Raubo, Piotr; Evans, Richard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008269516

PCT Pub. Number WO2009/001132

Priority 60/946,415 27.06.07 US; 61/029,444 18.02.08 US; 60/978,167 08.10.07 US

Filing date 25 June 2008

Wipo publication date 31 December 2008

Acceptance publication date 17 November 2011

International Classifications

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/454 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2009/001132 Priority application(s): WO2009/001132

17 November 2011 Application Accepted

  Published as AU-B-2008269516

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008269528-Pharmaceutical aerosol compositions comprising fluticasone

2008269513-1-cyanocyclopropyl-derivatives as cathepsin K inhibitors